Pancreatic cancer

April 15, 2022

News in Brief, April 2022

Summaries and links to timely information about research results in medical journals, recognition of research leaders, and more
August 17, 2021

EA2185 Pancreatic Cyst Surveillance Study: Amendment #2 Highlights

This study is evaluating two different screening strategies for non-cancerous pancreatic cysts; recently activated amendment #2 expands the eligibility criteria
July 7, 2021

Trial Spotlight: Efrat Dotan on the GIANT Study for Older Adults with Pancreatic Cancer

The GIANT trial (EA2186) is the first randomized clinical trial to focus on vulnerable older adults with treatment-naïve metastatic pancreatic cancer who are not candidates for standard therapy
May 28, 2021

Now Enrolling: EA2192/APOLLO for Pancreatic Cancer

This phase II study, led by Dr. Kim Reiss Binder, is exploring whether the addition of maintenance PARP inhibition for BRCA- or PALB2-mutated pancreatic cancer improves outcomes
July 29, 2020

Now Enrolling: EA2186 / GIANT for Advanced Pancreas Cancer in Older Adults

Currently, there is no treatment standard for metastatic pancreatic cancer in people aged 65 years and older